Year: 2016
Type: article
Abstract: Precision treatment with targeted cancer drugs requires the selection of patients who are most likely to benefit from a given therapy. We argue here that the use of a combination of both DNA and transcriptome analyses will significantly improve drug response prediction.
Source: Cancer Discovery
Authors: Emile E. Voest, Rene Bernards
Institution: The Netherlands Cancer Institute
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: bronze
Award: G5869732512
OpenAlex ID: W2262473824
